The EMA's human medicines committee has started a review of oral complement C5 inhibitor Tavneos, prompted by information that the regulator says raises questions about the integrity of the data from ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Analysts say Bitcoin’s volatile price action reflects an increasing risk of distribution as new BTC whales dominate short-term flows. Is a drop to $85,000 in play for the short term? New BTC whales ...

Bitcoin price slips below $93,000 on Monday, retesting its key 50-day EMA. Investors move toward safe-haven assets while risky assets such as BTC dip amid escalating EU–US trade-war fears. US-listed ...

Renewed spot Ethereum ETF inflows topped $474 million this week while network metrics smashed records, positioning ETH for a rally to $4,500 in the coming weeks. Spot Ethereum ETFs recorded $474.6 ...

Bitcoin stays above $95,000, supported by growing institutional demand, with ETF inflows reaching $753 million on Tuesday. Ethereum is poised to extend its rebound above the 100-day EMA, supported by ...

XRP continues to struggle at the $2.00 psychological level, with elevated volume signaling aggressive selling into strength even as broader institutional narratives remain supportive. XRP price action ...

A novel non-antibiotic approach to diarrhea treatment is important because there are no FDA-approved drugs to treat general diarrhea in dogs, the second most common reason for visits to veterinary ...